Kadcyla 100mg Injection: Effective Treatment for Cancer Patients

Description:

• Consists of the active ingredient Ado-Trastuzumab emtansine.
• Prescription medication used to treat HER2-positive breast cancer that has spread to other parts of the body or has not responded to other treatments.
• Combination of two drugs: trastuzumab (an antibody that targets HER2 receptors) and emtansine (a chemotherapy drug that kills cancer cells).

Uses:

• Advanced and metastatic breast cancer.
• Metastatic gastric cancer.

Therapeutic Effects:

• Binds to HER2-positive cancer cells and releases emtansine, which enters the cancer cells and destroys them.
• Helps to slow down or stop the growth of cancer, reducing the size of tumors and potentially extending the patient's life.

Interaction with Other Drugs:

• Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment.
• Certain medications may interact with Kadcyla 100mg Injection and cause undesirable side effects.

Storage:

• Store in a refrigerator at 2°C to 8°C (36°F to 46°F).
• Protect from light.
• Keep in its original packaging until it is ready to be used.
• Keep out of reach of children and pets.
• Dispose of properly.

Administration:

• Administered by a healthcare professional in a hospital or clinic setting.
• Dose and frequency depend on several factors, such as the individual's age, weight, overall health, and the type and stage of the cancer being treated.

Safety Advices:

• Pregnancy: discuss with your physician before taking if you are pregnant or think you might be pregnant.
• Breastfeeding: avoid breastfeeding while on the treatment and at least seven months after the final dose.
• Lungs: patients with pre-existing lung conditions should consult a doctor before taking it.
• Liver: can affect liver function, and in rare cases, it can cause liver damage.
• Alcohol: avoid consuming alcohol while taking Ado-Trastuzumab Emtansine.
• Driving: can cause unusual tiredness and dizziness, so avoid driving or handling machinery during the treatment.

Side Effects:

• Serious: infusion reactions, lung problems, heart problems, severe bleeding or bruising, nerve damage, severe allergic reactions.
• Common: fatigue, nausea, constipation, muscle or joint pain, headache, fever, low platelet count, high liver enzyme levels, low red blood cell count, loss of appetite, rash or itching.

Word of Advice:

• Be proactive in managing your treatment and monitoring your symptoms.
• Keep communication with your healthcare provider and report any concerns or side effects as soon as possible.
• Avoid getting pregnant and breastfeeding during treatment.
• Take steps to care for yourself physically and emotionally during treatment, and seek support from loved ones and professionals as needed.
• Maintain a healthy and balanced diet during treatment to support your overall health and well-being.

FAQs:

1. Can Kadcyla 100mg Injection cause nerve damage?

• Kadcyla 100mg Injection can cause peripheral neuropathy, a type of nerve damage that can cause tingling, numbness, or weakness in the hands and feet.

2. Does Kadcyla 100mg Injection cause infertility?

• Kadcyla 100mg Injection can cause temporary infertility in some patients, particularly women.

3. How is Kadcyla 100mg Injection different from traditional chemotherapy?

• Ado-Trastuzumab Emtansine is a type of chemotherapy, but it is designed to target HER2-positive cancer cells specifically, which may result in fewer side effects than traditional chemotherapy.

4. Can Kadcyla 100mg Injection be used in combination with other cancer treatments?

• Kadcyla 100mg Injection may be used in combination with other cancer treatments, such as chemotherapy or targeted therapies.

5. Can I take Kadcyla 100mg Injection if I have tuberculosis?

• The use of Kadcyla 100mg Injection in patients with active tuberculosis (TB) is not recommended due to the risk of worsening the TB infection.

6. Can Kadcyla 100mg Injection cause heart problems?

• Kadcyla 100mg Injection can cause heart problems, particularly in patients with preexisting heart conditions or risk factors.

Fact Box:

• Molecule name: Ado-Trastuzumab Emtansine.
• Therapeutic class: Anti-cancer.
• Pharmacological class: HER2 inhibitor.
• Indications: Advanced and metastatic breast cancer, metastatic gastric cancer.

Теги: cancer_treatment, breast_cancer, chemotherapy, drugs, injection, oncology